Teva Pharmaceutical Price
Market Closed9,432.00₺ %1.80+167.00
Last update:
High9.515,00 ₺
Low9.221,00 ₺
Volume1.91M
Market Cap109.83B
As of June 21, 2026, Teva Pharmaceutical stands at 9,432 ₺, a +1.80% change over the last 24 hours.
52W Low: 5,305.0056.03%52W High: 11,350.00
- Open
- 9,261.00
- P/E
- 24.06
- Forward P/E
- 34.05
- P/B
- 13.35
- EPS (TTM)
- 3.92
- Forward EPS
- 2.77
- Book Value
- 7.066
- Dividend Yield
- 0.00% (0.00)
- 50-Day Avg
- 9,891.72
- 200-Day Avg
- 9,071.60
- Avg Volume (3M)
- 1.23M
- Shares Outstanding
- 1.16B
- Bid / Ask
- 0.00 / 9,432.00
- Next Earnings
- Jul 29, 2026
- Exchange
- Tel Aviv
- Market State
- Closed
What Is Teva Pharmaceutical?
Teva Pharmaceutical (TEVA.TA) is a company share traded on Borsa İstanbul. This page shows the last trade price, daily change, and intraday movement for Teva Pharmaceutical. Data is updated during Borsa İstanbul session hours.
The Teva Pharmaceutical price is determined by supply and demand. The company's financial performance, sector dynamics, and the macro environment are the main determinants.
Factors Affecting the Teva Pharmaceutical Price
- Company quarterly financial results (EBITDA, net profit)
- Sector dynamics and the competitive environment
- Dividend policy and capital increase decisions
- Inclusion in/exclusion from BIST indices (liquidity effect)
- Macro conditions and the foreign ownership ratio
Frequently Asked Questions
- What is Teva Pharmaceutical?
- Teva Pharmaceutical (TEVA.TA) is a publicly traded company on Borsa İstanbul. Its shares are bought and sold under the symbol "TEVA.TA".
- What are the Teva Pharmaceutical trading hours?
- On Borsa İstanbul, pre-opening is 09:40-09:55 and continuous trading is 10:00-18:00 (lunch break 13:00-14:00).
- How is the Teva Pharmaceutical price determined?
- It is the last trade price at which buyer and seller are matched in the continuous auction system. The best bid and ask levels in the order book indicate liquidity.
- When does dividend distribution for Teva Pharmaceutical occur?
- Teva Pharmaceutical dividend distribution is determined by a general assembly decision; for past-year dividends you can follow the PDP (KAP) announcements.